{"pub": "reuters", "url": "https://uk.reuters.com/article/uk-britain-stocks/ftse-100-heads-for-fourth-session-of-gains-idUKKBN1X30OV", "downloaded_at": "2019-10-24 07:54:45.573988+00:00", "title": "FTSE 100 heads for fourth session of gains", "language": "en", "text": "Traders are seen at work at Northern Trust offices in London, Britain August 1, 2019. REUTERS/Toby Melville/Files\n\n(Reuters) - London\u2019s FTSE 100 held firm at a near one-month high on Thursday as gains in AstraZeneca after a 2019 target upgrade countered losses in Royal Bank of Scotland following a weak third-quarter update, while midcaps outperformed as sterling rose.\n\nThe blue-chip index .FTSE inched up by 0.1% at 0708 GMT, while the FTSE 250 index .FTMC gained 0.2%.\n\nAstraZeneca (AZN.L) added 2.3% after the pharmaceutical giant raised its annual product sales forecast for the second time this year, thanks in part to strong demand for new cancer treatments.\n\nOn the other end of the spectrum was Royal Bank of Scotland (RBS.L) that skidded 3% as it swung to a third-quarter loss due to a fresh 900 million pound provision to settle mis-selling claims in Britain\u2019s biggest consumer banking scandal.", "description": "London's FTSE 100 held firm at a near one-month high on Thursday as gains in AstraZeneca after a 2019 target upgrade countered losses in Royal Bank of Scotland following a weak third-quarter update, while midcaps outperformed as sterling rose.", "authors": ["Reuters Editorial", "Min Read"], "top_image": "https://s4.reutersmedia.net/resources/r/?m=02&d=20191024&t=2&i=1444403884&w=1200&r=LYNXMPEF9N0FV", "published_at": "2019-10-24"}